杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/07/25 | 1,707 | 1,715 | 1,699 | 1,707 | -4 | -0.2% | 151,800 |
| 2024/07/24 | 1,714 | 1,721 | 1,705 | 1,711 | -10 | -0.6% | 92,100 |
| 2024/07/23 | 1,705 | 1,721 | 1,705 | 1,721 | +16 | +0.9% | 74,500 |
| 2024/07/22 | 1,726 | 1,731 | 1,705 | 1,705 | -24 | -1.4% | 98,000 |
| 2024/07/19 | 1,721 | 1,729 | 1,709 | 1,729 | ±0 | ±0% | 83,300 |
| 2024/07/18 | 1,710 | 1,734 | 1,710 | 1,729 | +10 | +0.6% | 84,700 |
| 2024/07/17 | 1,715 | 1,719 | 1,705 | 1,719 | +14 | +0.8% | 61,900 |
| 2024/07/16 | 1,716 | 1,723 | 1,705 | 1,705 | -23 | -1.3% | 86,300 |
| 2024/07/12 | 1,707 | 1,728 | 1,707 | 1,728 | +14 | +0.8% | 103,900 |
| 2024/07/11 | 1,704 | 1,718 | 1,704 | 1,714 | +14 | +0.8% | 99,500 |
| 2024/07/10 | 1,700 | 1,702 | 1,688 | 1,700 | ±0 | ±0% | 79,500 |
| 2024/07/09 | 1,688 | 1,706 | 1,685 | 1,700 | +17 | +1% | 113,500 |
| 2024/07/08 | 1,699 | 1,702 | 1,677 | 1,683 | ±0 | ±0% | 157,200 |
| 2024/07/05 | 1,695 | 1,698 | 1,678 | 1,683 | -17 | -1% | 90,900 |
| 2024/07/04 | 1,695 | 1,700 | 1,694 | 1,700 | +9 | +0.5% | 62,900 |
| 2024/07/03 | 1,691 | 1,699 | 1,688 | 1,691 | -3 | -0.2% | 69,300 |
| 2024/07/02 | 1,698 | 1,704 | 1,691 | 1,694 | -3 | -0.2% | 77,900 |
| 2024/07/01 | 1,706 | 1,706 | 1,692 | 1,697 | -5 | -0.3% | 92,500 |
| 2024/06/28 | 1,704 | 1,706 | 1,692 | 1,702 | ±0 | ±0% | 70,800 |
| 2024/06/27 | 1,710 | 1,710 | 1,695 | 1,702 | -12 | -0.7% | 75,500 |
| 2024/06/26 | 1,705 | 1,717 | 1,697 | 1,714 | +8 | +0.5% | 93,600 |
| 2024/06/25 | 1,722 | 1,722 | 1,703 | 1,706 | -11 | -0.6% | 204,700 |
| 2024/06/24 | 1,715 | 1,720 | 1,704 | 1,717 | +20 | +1.2% | 91,300 |
| 2024/06/21 | 1,703 | 1,718 | 1,693 | 1,697 | -12 | -0.7% | 208,800 |
| 2024/06/20 | 1,693 | 1,713 | 1,693 | 1,709 | +9 | +0.5% | 91,300 |
| 2024/06/19 | 1,697 | 1,701 | 1,686 | 1,700 | +9 | +0.5% | 71,300 |
| 2024/06/18 | 1,676 | 1,694 | 1,676 | 1,691 | -4 | -0.2% | 61,100 |
| 2024/06/17 | 1,685 | 1,695 | 1,674 | 1,695 | +12 | +0.7% | 72,500 |
| 2024/06/14 | 1,690 | 1,698 | 1,680 | 1,683 | +2 | +0.1% | 89,200 |
| 2024/06/13 | 1,685 | 1,687 | 1,675 | 1,681 | -11 | -0.7% | 47,700 |
| 2024/06/12 | 1,699 | 1,705 | 1,688 | 1,692 | -2 | -0.1% | 67,400 |
| 2024/06/11 | 1,687 | 1,699 | 1,683 | 1,694 | +4 | +0.2% | 64,900 |
| 2024/06/10 | 1,669 | 1,693 | 1,664 | 1,690 | +33 | +2% | 87,800 |
| 2024/06/07 | 1,655 | 1,662 | 1,646 | 1,657 | +3 | +0.2% | 109,000 |
| 2024/06/06 | 1,674 | 1,677 | 1,648 | 1,654 | -20 | -1.2% | 187,700 |
| 2024/06/05 | 1,686 | 1,688 | 1,664 | 1,674 | -15 | -0.9% | 205,000 |
| 2024/06/04 | 1,703 | 1,703 | 1,687 | 1,689 | -26 | -1.5% | 156,700 |
| 2024/06/03 | 1,716 | 1,731 | 1,713 | 1,715 | ±0 | ±0% | 51,900 |
| 2024/05/31 | 1,720 | 1,729 | 1,712 | 1,715 | -1 | -0.1% | 306,100 |
| 2024/05/30 | 1,695 | 1,716 | 1,691 | 1,716 | +13 | +0.8% | 57,900 |
| 2024/05/29 | 1,705 | 1,717 | 1,699 | 1,703 | -2 | -0.1% | 38,500 |
| 2024/05/28 | 1,710 | 1,712 | 1,700 | 1,705 | -2 | -0.1% | 33,100 |
| 2024/05/27 | 1,702 | 1,708 | 1,695 | 1,707 | +5 | +0.3% | 61,300 |
| 2024/05/24 | 1,690 | 1,705 | 1,690 | 1,702 | +14 | +0.8% | 103,600 |
| 2024/05/23 | 1,697 | 1,709 | 1,687 | 1,688 | -9 | -0.5% | 78,800 |
| 2024/05/22 | 1,708 | 1,715 | 1,697 | 1,697 | -17 | -1% | 107,500 |
| 2024/05/21 | 1,726 | 1,735 | 1,713 | 1,714 | -1 | -0.1% | 70,400 |
| 2024/05/20 | 1,712 | 1,716 | 1,705 | 1,715 | +3 | +0.2% | 84,400 |
| 2024/05/17 | 1,710 | 1,716 | 1,703 | 1,712 | +2 | +0.1% | 107,100 |
| 2024/05/16 | 1,725 | 1,725 | 1,705 | 1,710 | -18 | -1% | 86,100 |
201～
250
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 81,800円 | +20.3% | - | 0.00% | 145.04倍 | 1.08倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
